Cardio Diagnostics Holdings, Inc. financial data

Symbol
CDIO, CDIOW on Nasdaq
Location
Chicago, IL
Fiscal year end
31 December
Latest financial report
10-Q - Q3 2025 - 12 Nov 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 1802% % 294%
Debt-to-equity 8% % -76%
Return On Equity -68% % 74%
Return On Assets -62% % 67%
Operating Margin -41422% % -76%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 1,826,051 shares -95%
Common Stock, Shares, Outstanding 1,766,607 shares -94%
Entity Public Float $10,700,000 USD 14%
Common Stock, Value, Issued $18 USD -94%
Weighted Average Number of Shares Outstanding, Basic 1,757,900 shares 116%
Weighted Average Number of Shares Outstanding, Diluted 1,757,900 shares 116%

Income Statement

Label TTM Value / Value Unit Change %
Revenues $15,782 USD -56%
Research and Development Expense $360,103 USD 1067%
Selling and Marketing Expense $189,864 USD 32%
General and Administrative Expense $5,587,559 USD -41%
Operating Income (Loss) $6,537,258 USD 22%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest $6,552,107 USD 21%
Net Income (Loss) Attributable to Parent $6,552,107 USD 21%
Earnings Per Share, Basic 6 USD/shares 43%
Earnings Per Share, Diluted 6 USD/shares 43%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value $0 USD
Accounts Receivable, after Allowance for Credit Loss, Current $11,221 USD -20%
Assets, Current $6,927,472 USD 164%
Property, Plant and Equipment, Net $744,335 USD 5.3%
Operating Lease, Right-of-Use Asset $303,767 USD -36%
Assets $8,788,902 USD 96%
Liabilities, Current $398,448 USD 29%
Operating Lease, Liability, Noncurrent $238,883 USD -51%
Liabilities $637,331 USD -20%
Retained Earnings (Accumulated Deficit) $27,784,632 USD -31%
Stockholders' Equity Attributable to Parent $8,151,571 USD 121%
Liabilities and Equity $8,788,902 USD 96%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities $1,400,101 USD -14%
Net Cash Provided by (Used in) Financing Activities $3,308,748 USD 109%
Net Cash Provided by (Used in) Investing Activities $47,415 USD 32%
Common Stock, Shares Authorized 300,000,000 shares 0%
Common Stock, Shares, Issued 1,766,607 shares -94%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $6,355,218 USD 221%
Interest Paid, Excluding Capitalized Interest, Operating Activities $4,691 USD -19%
Deferred Tax Assets, Valuation Allowance $5,607,531 USD 33%
Deferred Tax Assets, Gross $5,607,531 USD 33%
Operating Lease, Liability $605,089 USD -27%
Depreciation $153,279 USD 95%
Payments to Acquire Property, Plant, and Equipment $5,787 USD -71%
Lessee, Operating Lease, Liability, to be Paid $511,377 USD -34%
Operating Lease, Liability, Current $247,714 USD 5.9%
Lessee, Operating Lease, Liability, to be Paid, Year Two $250,152 USD -4%
Lessee, Operating Lease, Liability, to be Paid, Year One $65,610 USD 1.2%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount $36,463 USD -46%
Lessee, Operating Lease, Liability, to be Paid, Year Three $102,060 USD -59%
Deferred Tax Assets, Operating Loss Carryforwards $5,580,034 USD 32%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 100,000,000 shares 0%
Lessee, Operating Lease, Liability, to be Paid, Year Four $93,555 USD -8.3%
Operating Lease, Payments $64,827 USD 1.2%
Additional Paid in Capital $35,936,185 USD 44%
Preferred Stock, Shares Outstanding 0 shares
Amortization of Intangible Assets $9,333 USD -42%
Interest Expense $15,636 USD -19%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%